Purchase Order FA442723P0077
Award Date 8/10/23
Potential Completion Date 8/9/28
Potential Value $197K
Funding Federal Agency
Contracting Federal Agency
Ultimate Awardee
NAICS Category
PSC Category
Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
- Not listed
Extent Competed
Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Travis AFB, Fairfield, CA, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
4
Legislative Mandate
Clinger Cohen Act
National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This firm fixed-price purchase order contract was awarded by the Department of the Army Medical Command to Revvity Omics Inc., doing business as Perkinelmer Genetics, for comprehensive newborn screening services. The contract has a potential value of $375,186.00 and a completion date of September 30, 2016. Perkinelmer Genetics, a for-profit subsidiary of Revvity Inc., specializes in medical imaging and genetic testing services. This contract supports the military healthcare system by providing...
- This is a firm fixed-price contract awarded by the U.S. Army Medical Command (MEDCOM) to Revvity Omics Inc., doing business as Perkinelmer Genetics, for $99,600.00. The contract is for newborn screening services, which involve testing infants for conditions such as galactosemia, hypothyroidism, sickle cell disease, and cystic fibrosis. Perkinelmer Genetics, a subsidiary of Revvity Inc., is the prime contractor and will perform the screening tests at its own laboratories. This contract does not...
- This contract was awarded by the U.S. Department of the Army Medical Command to Perkinelmer Genetics, Inc., a for-profit medical services provider, to conduct newborn screening testing. The contract has a firm fixed price of $148,000.00 and a completion date of September 30, 2020. Perkinelmer Genetics, a subsidiary of the parent company Revvity Inc., specializes in newborn and genetic screening services to support military hospitals and treatment facilities in the U.S. and overseas. This...
- This is a firm fixed price contract awarded by the U.S. Department of Defense's Medical Command (MEDCOM) to Revvity Omics Inc., doing business as Perkinelmer Genetics, for $91,840.00. The contract is for newborn screening services, which involves testing infants for conditions such as galactosemia, hypothyroidism, sickle cell disease, and cystic fibrosis. Perkinelmer Genetics is the prime contractor and does not appear to have any major subcontractors. This contract is not associated with a...
- This is a delivery order contract awarded by the Medical Command, a defense agency, to Revvity Omics Inc., doing business as Perkinelmer Genetics, for a total ceiling value of $82,500.00. The contract is for newborn screening testing services to be provided in Germany. The award is not associated with a larger contract vehicle, and there is no set-aside designation indicated. Perkinelmer Genetics is a subsidiary of the parent company Revvity Inc., which specializes in medical imaging and genetic...
- The Department of the Army Medical Command awarded a Firm Fixed Price Blanket Purchase Agreement (BPA) call to Perkinelmer Genetics, Inc., a for-profit organization, to provide newborn screening tests. The contract has a potential value of $143,440.00 and a performance period ending on September 30, 2018. Perkinelmer Genetics, a subsidiary of Revvity Inc., specializes in newborn and genetic screening services, and has provided similar testing support to military hospitals and treatment...
- This is a firm fixed-price blanket purchase agreement (BPA) call award issued by the U.S. Army Medical Command (MEDCOM) to Revvity Omics Inc., doing business as Perkinelmer Genetics. The $150,000.00 contract is for newborn screening tests and does not have a set-aside designation. Perkinelmer Genetics is a for-profit subsidiary of Revvity Inc. that specializes in medical imaging and genetic testing services, particularly newborn screening programs that test infants for conditions like...
- This federal contract award is for newborn screening testing services provided by Revvity Omics Inc., doing business as Perkinelmer Genetics, to the Defense Health Agency (DHA) for the Brian D. Allgood Army Community Hospital (BDAACH) in South Korea. The contract is a firm fixed price delivery order under a larger indefinite delivery, indefinite quantity (IDIQ) contract awarded to Perkinelmer Genetics in 2019 by the DHA to provide newborn screening for Army medical facilities in Korea. The...
- The Defense Health Agency awarded a firm fixed-price purchase order valued at $848,688 to Revvity Omics Inc. (doing business as PerkinElmer Genetics) on October 1, 2024, for newborn genetic testing services at William Beaumont Army Medical Center in Fort Bliss, Texas. The contract extends through September 30, 2029, with no small business set-aside designation. The award fulfills a Department of the Army Medical Command solicitation issued in July 2024 seeking a contractor to conduct a...
- This contract was awarded by the Department of the Army Medical Command to Perkinelmer Genetics, Inc., a for-profit organization, to provide newborn screening testing services. The contract is a Blanket Purchase Agreement (BPA) call with a firm fixed price, and has a potential value of $150,000.00. The services under this contract include testing newborns for conditions such as glucose-6-phosphate dehydrogenase deficiency, galactosemia, congenital hypothyroidism, and hemoglobinopathies. These...